Related Business Topics
Latest Headlines
Reuters - Nov. 25, 2009, 7:02 AM
- Agreement Provides Financial Flexibility, Allowing Company to Access Capital at its Discretion - LAVAL, Quebec, Nov. 25 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS; NASDAQ: DDSS) today announced it has entered into a standby equity distribution ...
Forbes.com - Nov. 25, 2009, 6:52 AM
Nov 25 (Reuters) - Labopharm Inc: * Enters into CAD$25 million standby equity distribution agreement * Says has entered into a standby equity distribution agreement with Ya Global Master Spv * Says Ya has committed to provide up to $25 million of ...
Forbes.com - Nov. 10, 2009, 12:02 PM
LAVAL, QC The article is authored by Dr. Stephen Stahl, adjunct professor of psychiatry, University of California, San Diego School of Medicine as part of a series entitled Trends in Psychopharmacology, the Mechanism of Action of Trazodone: A ...
Reuters - Nov. 6, 2009, 7:58 AM
* Q3 loss C$0.12/shr vs loss C$0.11/shr year-ago * Revenue falls 30 pct to C$6.6 mln * Says to cut 35 jobs Nov 6 (Reuters) - Labopharm Inc (DDS.TO) (DDSS.O) posted a wider quarterly loss, as the Canadian drugmaker earned lower licensing revenue from its ...
Forbes.com - Oct. 20, 2009, 12:15 PM
BusinessWire - --Hercules Recognizes Three Additional Portfolio Company Events From Labopharm, Inc., and QuatRx Pharmaceuticals That Reinforce Early, Positive Signs within the Market as Well as Ancestry.com, Pending IPO Hercules Technology Growth ...
Reuters - Oct. 7, 2009, 10:33 AM
* Drugmaker satisfies all FDA manufacturing concerns * Analyst sees approval in early 2010 * Labopharm shares up 31 percent to C$1.90 (Adds details and updates stock price.) TORONTO, Oct 7 (Reuters) - Labopharm Inc's (DDS.TO) shares soared on Wednesday ...
